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Abstract: Surface functionalization of hydroxyapatite (HA) and β-tricalcium phosphate (TCP) bioceramics with
chemical ligands containing apyrrogallolmoietywasdeveloped to improve the adhesion of bone cell precursors to
the biomaterials. Fast and biocompatible copper-free click reaction with azido-modified human fetal osteoblasts
resulted in improved cell binding to both HA and TCP bioceramics, opening the way for using this methodology
in the preparation of cell-engineered bone implants.
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Introduction
Over the last decade, bone-related
diseases such as osteogenesis imperfecta,
osteoarthritis, osteomyelitis, and osteo-
porosis, traumatic injuries and orthope-
dic surgeries have dramatically increased.
The reasons for this drastic development
can be found in the ageing of the popula-
tion and the democratization of high-risk
sports.
[1]
The current gold standard to treat
large bone defects is still autologous iliac
crest graft.
[2]
Another option for patients
and surgeons is the use of allograft-based
bone tissue from other humans and in most
cases from cadavers. Many orthopedic al-
lograft procedures have been approved by
the FDA and applied for years in hospitals.
Success in both allografts and autografts
results from the physical and biological
similarity between the donor and host tis-
sue.
[3]
Nevertheless, the need for a second
surgery with its increased risk of infection,
pain, donor site morbidity, disease trans-
mission and rejection (in the case of al-
lografts), as well as monetary aspects call
for the development of synthetic bone graft
materials which today are used in only
15% of cases.
[1]
Recent advances in the un-
derstanding of the chemical and biological
processes of bone tissue regeneration have
led to a new generation of synthetic bone
substitute materials that show good poten-
tial for the treatment of large bone defects.
One of the biggest challenges in bone
tissueengineering is thecomplete coloniza-
tion of the graft biomaterial by osteoblasts,
especially in the inner area of implants.
Due to the lower availability of nutrients
and oxygen, the cells present in the inner
area migrate to the surface. To overcome
this problem we propose to establish a co-
valent linkage between implant materials
and human fetal osteoblasts (FsOs) allow-
ing a better colonization of the scaffold.
These cells have an interesting potential
for therapeutic use in bone tissue engineer-
ing, due to their rapid growth rate, their
ability to differentiate in vitro into mature
osteoblasts and their histocompatibility.
[4,5]
During the last decade, thedevelopment
of bioorthogonal ligation has improved the
possibility to study cellular processes.
[6]
Among the chemical motifs developed
for these reactions, azide appears as
one of the most versatile bioorthogo-
nal reporters due to its stability under
physiological conditions and its small
size that has generally only minimal ef-
fects on the structure of the tagged
molecules.
[7]
Azides can react through
Staudinger ligation with triarylphos-
phines and dipolar cycloadditions to al-
kynes, under mild reaction conditions.
[8,9]
In this study, copper-free [3 + 2] dipolar
cycloaddition (click reaction)
[10]
was in-
vestigated to form a covalent linkage be-
tween modified FsOs and biomaterials.
[11]
Wedisclose herein the synthesis of a chem-
ical ligand containing an activated alkyne
for the copper-free click reaction and its
ligation to azido-modified FsOs. The cy-
totoxicity of this reaction for the cells was
also evaluated for several days. We also
determined whether the adhesion of FsOs
to bioceramics of different compositions
– hydroxyapatite (HA) and β-tricalcium
phosphate (TCP) – can be improved by
chemical functionalization of the scaffold
with a specific ligand allowing the copper-
free click reaction with FsOs.
[12]
Results
Synthesis of the Chemical Ligand
for the Copper-free Click Reaction
The synthesis of activated cyclooc-
tyne, DIBO, was performed according to
the published data.
[13]
After activation with
4-nitrophenyl chloroformate to give car-
bonate 2, the resulting intermediate was
treated with derivative 3 containing a tet-
raethyleneglycol chain required for higher
solubility in biological medium and a bio-
tin label for the detection with a fluores-
cent streptavidin to afford the model ligand
4 used for further evaluation of the copper-
free click reaction on azido-modified FsOs
(Scheme 1).
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Then the azido-labeled FsOs (10
5
cells per
disc of biomaterial) were added to bioma-
terial discs which were either unfunction-
alized or had been pre-functionalized with
compound 8. After the washing and fixa-
tion steps, the cells were stained with crys-
tal violet. Cell adhesion to the biomaterials
was imaged with a stereomicroscope and
the number of adhered cells was quantified
Synthesis of the Chemical Ligand
for the Copper-free Click Reaction
on Biomaterials
3,4,5-Triacetoxy benzoic acid (5) was
first converted into the corresponding acyl
chloride by reaction with oxalylchloride in
the presence of DMF and then coupled to
N-Boc-1,6- hexanediamine to afford in-
termediate 6. After cleavage of the carba-
mate under acidic conditions, the resulting
amine 7 reacted with activated DIBO 2 in
the presenceof triethylamine.Deprotection
of the three hydroxyl groups under basic
conditions provided the desired compound
8 which was further used for the function-
alization of the biomaterial and the click
reaction with FsOs (Scheme 2).
Copper-free Click Reaction with
FsOs
Compound 4 presenting activated cy-
clooctyne can react with azide moieties
without copper catalyst since the loss of
the ring strain (18 kcal/mol) and the ad-
ditional strain imposed by two aromatic
rings decrease the activation energy of the
click reaction. In order to express azido-
modified proteins, human fetal osteoblasts
were cultured in the presence of the non-
natural amino acid l-azidohomoalanine
(AHA) to insert an azide moiety in cel-
lular proteins, without cell alterations.
[8]
Copper-free click reaction of compound
4 (Fig. 1A–D) with azido-modified FsOs
was performed at room temperature for
1 h in culture medium without FCS, con-
taining additional HEPES (20 µM) for
buffering. Cell nuclei were labeled with
DAPI and the cell functionalization was
monitored by fluorescence microscopy
using Cy3-streptavidin. In the absence of
preincubation of cells with AHA no label-
ing was detected. Ligand 4, containing an
activated alkyne moiety, allowed fast click
reactions with azido-modified FsOs at the
concentration of 20, 50 and 100 µM in the
incubation medium (Fig. 1).
Evaluation of the Cytotoxicity of
the Copper-free Click Reaction on
FsOs
The biocompatibility of this reaction
was evaluated by monitoring the cell vi-
ability using the WST-1 assay of func-
tionalized FsOs for up to 144 h after the
chemical reaction (Fig. 2). No cytotoxicity
on FsOs was observed for the copper-free
click reaction. This technique can thus be
further applied to long-term cellularization
of implant biomaterials.
Click Reaction on HA and TCP
Biomaterials
After having proved that copper-free
click reaction can be used as an efficient
tool for the functionalization of FsOs sur-
face, we further investigated this reaction
with ligands conjugated to biomaterials
of different chemical compositions. For
that purpose, the ligand 8 combining a
pyrrogallol moiety for attachment to the
inorganic matrix of the biomaterial
[14]
and
DIBO was used. The hydroxyapatite (HA)
and β-tricalcium phosphate (TCP) bioma-
terials were functionalized by incubation
with a 0, 5 or 10 µM solution of 8 for 24 h.
HO
1
NEt
3
, DMF,
88 %
O
O
O
NO
2
DIPEA, PyBOP
CH
2
Cl
2
, 20 %
O
N
H
O
O
N
H
O
S
NH
HN
O
3
2
4
H
H
O
O
Cl
NO
2
O
N
H
O
S
HN
NH
O
H
2
N
3
3
H
H
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of the model linker for
the copper-free click
reaction on FsOs.
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of the ligand for the
copper-free click
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Fig. 1. Copper-free click reactions performed on FsOs. (A) To evaluate
the non-specific binding, FsOs without preincubation with AHA were
exposed to biotin-containing compound 4, then to fluorescent Cy3-
streptavidin to label biotin and DAPI to label cell nuclei. (B–D) FsOs were
preincubated with AHA and subsequently exposed to compound 4 (20,
50, 100 µM) for 1 h at 25 °C using copper-free click reaction, then to
fluorescent streptavidin to label biotin and to DAPI to label cell nuclei.
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acid AHA. A 50 to 100 µM concentration
of ligand 4 was optimal to achieve a high
rate of functionalization. Then the viability
of functionalized FsOs was evaluated for
up to 144 hours after the click reaction. No
decrease of the cell survival was observed
compared to the non-functionalized cells,
suggesting that this modification is not
toxic for FsOs.
A second chemical ligand 8 contain-
ing a pyrrogallol moiety for the binding
to the biomaterial discs
[14]
and a cyclic ac-
tivated alkyne for the covalent linkage to
FsOs was synthesized in reasonable yield.
The HA and TCP biomaterials were then
functionalized at different concentrations
with ligand 8 andAHA-labeled FsOs were
added. A significantly higher number of
adhered FsOs was observed on the func-
tionalized biomaterials and was strongly
correlated with the concentration of ligand
8 used for surface modification of the bio-
materials. Better results were obtained for
TCP bioceramic than HA bioceramic, the
number of adhered cells being higher with
this material. This observation was in ac-
cordance with previous results obtained for
other functionalizing ligands.
[15]
In conclusion, surface functionaliza-
tion of HA and TCP biomaterials provides
an efficient tool to promote the adhesion of
bone precursor cells to the scaffolds using
the copper free click reaction. The biocom-
patibility of this chemical transformation
opens the way to further development of
functionalized bioceramics as cell-engi-
neered bone implant materials.
Experimental Section
Chemical Syntheses
Commercial reagents (Fluka, Aldrich,
VWR, Switzerland) were used without fur-
ther purification. Anhydrous solvents were
obtainedby filtration (PureSolvMDSeries,
Innovative Technology). TLCs for reac-
tion monitoring were performed on Merck
silica gel 60 F254 plates, and spots were
revealed with UV light and reaction with
KMnO4 or ninhydrine. IR spectra were
recorded on a Perkin-Elmer-1420 spec-
trometer.
1
H-NMR spectra were recorded
on a Bruker ARX-400 spectrometer (400
MHz) using CDCl
3
or MeOD as solvent
and calibrated using the solvent’s residual
signal at 7.27 or 3.31 ppm as an internal
reference.
13
C-NMR spectra were recorded
on a BrukerARX-400 spectrometer (100.6
MHz) using CDCl
3
or MeOD as solvent
and calibrated using the solvent’s residual
signal at 77.0 or 49.0 ppm as an internal
reference. Chemical shifts are expressed
in parts per million (ppm) and coupling
constants (J) in Hertz. Mass spectra were
obtained on a Nermag R-10-10C spec-
trometer with chemical ionization (NH
3
)
by the IMAGE J software for each mate-
rial (Fig. 3). Quantification of the number
of bound cells to the discs of biomateri-
als showed that the functionalization of
the discs with compound 8 significantly (p
<0.001) increased the number of adhered
cells, with a very strong dependency (10
µM vs 5 µM: p <0.001, correlation = 1)
on the concentration of compound 8 used
for the functionalization of the two types
of biomaterials. No cells were bound on
the unfunctionalized discs of bioceramics.
TCP biomaterial showed a higher number
of bound cells compared to HA.
Discussion
The colonization of the inner surface of
bone substitutematerials by osteoblasts has
to be reached to ensure homogeneous bone
reconstruction and success of the implant.
In this study, copper-free click reaction on
human fetal osteoblasts was first evaluated
to determine if a chemical compound can
be bound to the cell surface without any
cytotoxicity.After the synthesis of a model
ligand 4 containing an activated alkyne, a
polyethylene chain and a biotin moiety, the
copper-free click reaction was performed
with this compound on modified FsOs and
monitored by fluorescence microscopy us-
ing a fluorescent streptavidin. Cell surface
modification was only observed on FsOs
pre-incubated with the non-natural amino
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Fig. 2. FsOs were pre-incubated overnight with AHA (C2 or 4) or with
vehicle as control (C1), then the copper-free click reaction was performed
for 1 h at 25 °C (4) or cells were incubated in complete medium for 1 h at
25 °C as control (C1 and C2). Cells were further incubated for 72 h to 144
h, and then the WST-1 assay was performed. Results are the means +sd
of triplicate wells of a representative experiment out of three independent
experiments.
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Fig. 3. The quantification of the number of cells adhered to the discs of bioceramics was per-
formed by analysis of stereomicroscopy pictures. A: HA and B: TCP. The number of cells bound
to the bioceramic discs was compared between unfunctionalized scaffolds (0 µM) and scaffolds
functionalized with compound 8 (5 µM or 10 µM) using a Student’s t-test : *** : p < 0.001. The
correlation coefficient (R
2
) was calculated between the number of adhered cells on scaffolds func-
tionalized with 5 µM and 10 µM of compound 8. R
2
= 1.00. Results are the mean ±sd of triplicates
of three independent experiments.
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and mode m/z (amu) [% relative base peak
(100%)]. Semi-preparative HPLC was
performed on a Waters Autopurification
ZQ System equipped with a 2767 Sample
Manager, a 2525 Binary Gradient Module
and a 2996 Photodiode Array Detector,
coupled toWatersMicromass ZQ analyzer.
The HPLC purifications were performed
on XTerra Prep RP C18 (19 × 150 mm)
columns, using reverse-phase conditions (2
to 100% acetonitrile with 0.1% TFA over
20 min). MS: Nermag R-10-10C, chemical
ionization (NH3) mode m/z (amu) [% rela-
tive base peak (100%)].
11,12-Didehydro-5,6-
dihydrodibenzo[a,e][8]annulen-5-yl
4-nitrophenyl Carbonate (2)
4-Nitrophenyl chloroformate (0.9 g,
4.6 mmol, 2 equiv.) and pyridine (0.9 mL,
11.4, 5 equiv.) were added to a solution of
11,12-didehydro-5,6-dihydrodibenzo[a,e]
[8]annulen-5-ol (1, 0.5 g, 3.6 mmol, 1
equiv.) in DCM (68 mL) and the reaction
mixture was stirred for 8 h at 25 °C. The so-
lution was washed with brine (2 × 23 mL).
The organic phase was dried with MgSO
4
and concentrated under reduced pressure.
The crude product was then purified by
flash column chromatography (PE/DCM
2:1) to give 2 as a white solid (0.8 g, 88%).
The analytical data were in accordance
with the reported characterization.
[13]
Preparation of Ligand 4
11,12-Didehydro-5,6-dihydrodi-
benzo[a,e][8]annulen-5-yl 4-nitrophenyl
carbonate (2, 0.67 g, 1.7 mmol, 1 equiv.)
was added to a solution of N-(2-{2-[2-
(2- aminoethoxy)ethoxy]ethoxy}ethyl)-
5-[(4R)-2-oxohexahydro-1H-thieno[3,4-
d]imidazol-4-yl]pentanamide (3, 0.72 g,
1.7 mmol, 1 equiv.) and triethylamine (0.7
mL, 5.2 mmol, 3 equiv.) in DMF (194mL),
under an argon atmosphere. The reaction
mixture was stirred overnight at rt, concen-
trated under reduced pressure and the resi-
duewas purified by silica gel flash chroma-
tography (DCM/MeOH98:2) to afford 4 as
a green solid (225 mg, 20 %). IR (film):
3330, 2920, 2865, 1780, 1705, 1520, 1450,
1330, 1205, 1075, 955, 925, 860, 815, 760,
730, 685, 645, 565, 545, 520, 515 cm
–1
.
1
H-NMR(400 MHz, CDCl
3
): δ = 7.52 (d,
1H, aromatic,
2
J = 7.6 Hz, CH (aromatic)),
7.41–7.26 (m, 7H, 7 CH (aromatics)), 5.50
(s, 1H, CH), 4.47 (m, 1H, CH), 4.29 (m,
1H, CH), 3.66–3.62 (m, 8H, 4 CH
2
), 3.60–
3.53 (m, 4H, 2 CH
2
), 3.47–3.36 (m, 4H,
2 CH
2
), 3.19–3.09 (m, 2H, 2 CH), 2.96–
2.86 (m, 2H, 2 CH), 2.71 (d, 1H,
2
J = 12.6
Hz, CH), 2.19 (t, 2H,
2
J = 7.7 Hz, CH
2
),
1.70–1.60 (m, 4H, 2 CH
2
), 1.45–1.40 (m,
2H, CH
2
).
13
C-NMR (101 MHz, CDCl
3
):
δ = 172.8, 130.0, 128.1, 127.1, 126.1,
123.8, 70.4, 70.1, 61.9, 60.3, 55.4, 46.2,
40.5, 39.2, 29.7, 28.0, 25.6, 25.4. HRMS
(ESI): (m/z): calcd for C
35
H
44
N
4
O
7
S+H:
665.3009, found: 665.3010. [α]
D
25
= 0.1 (c
= 0.1, DCM).
5-[(6-Aminohexyl)carbamoyl]ben-
zene-1,2,3-triyl Triacetate (7)
Few drops of DMF were added to
3,4,5-triacetoxy benzoic acid (1 g, 3.4
mmol, 1 equiv.) in dry DCM (6 mL). The
reaction was cooled to 0 °C and oxalyl-
chloride (0.31 mL, 3.7 mmol, 1.5 equiv.)
was added drop wise. After 15 min the
reaction mixture was allowed to reach rt
and stirred for 1 h. The solution was con-
centrated under reduced pressure and the
residue was suspended in dry DCM (4.5
mL). A solution containing N-Boc-1,6-
hexadiamine (0.72 g, 3.4 mmol, 1 equiv.)
andDIPEA (1.73mL, 10.1mmol, 3 equiv.)
in DCM (4.5 mL) was added drop wise at 0
°C. After 15 min the reaction mixture was
allowed to reach room temperature and
stirred for 1 h.The solutionwas concentrat-
ed under reduced pressure and the residue
was purified by flash column chromatogra-
phy (AcOEt/EP 1:1). The resulting product
was dissolved in 4 M HCl in dioxane and
stirred for 1 h at room temperature. HCl
was coevaporated three times with diethyl
ether to afford a white paste (400 mg, 30%
for 2 steps). IR (film): 3265, 2935, 2860,
2225,1770, 1635, 1585, 1550, 1490, 1435,
1370, 1315, 1180, 1120, 1050, 1010, 975,
890, 870, 820, 760, 730, 700 590 cm
–1
.
1
H NMR (400 MHz, MeOD): δ = 7.64 (s,
1H, CH), 3.39 (t, 2H, CH
2
), 2.92 (t, 1H,
CH
2
), 2.30 (s, 9H, 3 CH
3
), 1.66 (m, 4H, 2
CH
2
), 1.44 (m, 4H, 2 CH
2
).
13
C NMR (101
MHz,MeOD): δ = 169.50, 168.35, 133.72,
121.00, 40.81, 40.63, 30.1, 28.44, 27.32,
26.96, 20.38, 19.96. MS (ESI): HRMS
(ESI): (m/z): calcd for C
19
H
26
N
2
O
7
+H:
395.1818, found: 395.1823.
11,12-Didehydro-5,6-dihydrodi-
benzo[a,e][8]annulen-5-yl(6-
{[(3,4,5-trihydroxy phenyl)carbonyl]
amino}hexyl) Carbamate (8)
5-[(6-aminohexyl)carbamoyl]ben-
zene-1,2,3-triyl triacetate (7, 75 mg, 0.2
mmol, 1 equiv.) was dissolved in DMF (18
mL) and carbonic acid, 5,6-dihydro-11,12-
didehydro-dibenzo[a, e]cycloocten-5-yl
ester, 4-nitrophenyl ester (2, 80 mg, 0.2
mmol, 1 equiv.), followed by triethylamine
(0.08 mL, 0.6 mmol, 3 equiv.) were added.
The reaction mixture was stirred overnight
at room temperature. DMF was removed
under reduced pressure and the product
was purified by flash column chromatog-
raphy (AcOEt/EP 1:1 then 2:1) (150 mg,
46%). The resulting intermediate (33 mg,
0.05 mmol, 1 equiv.) was dissolved in THF
at 0 °C and a 1 M solution of LiOH (0.15
mL, 0.15 mmol, 3 equiv.) was added. The
reaction was monitored by MS until total
conversion of the starting material. The
product was purified by HPLC ((XTerra
Prep RP C18, (25×150 mm Waters)) to
give 8 (10 mg, 38%). IR (film): 3275,
2935, 1695, 2595, 1515, 1450, 1330, 1200,
1135, 1035, 865, 755, 720, 645, 585 cm
–1
.
1
H NMR (400 MHz, MeOD): δ = 7.38 (d,
1H, aromatic, CH), 7.37–7.29 (m, 7H,
aromatics, (CH)
7
), 6.82 (s, 2H, (CH)
2
),
5.42 (m, 1H, C(1’)H), 3.22 (dd, 1H,
2
J =
15.0
3
J = 2.0 Hz, CH
2
), 3.11 (t, 2H,
2
J =
2.0 Hz, CH
2
), 2.82 (dd, 1H,
2
J = 15.0
3
J =
3.8 Hz, CH
2
), 1.60–1.29 (m, 10H, 5 CH
2
).
13
C NMR (100 MHz, MeOD): δ = 169.12,
156.64, 152.34, 151.03, 136.52, 129.57,
127.92, 127.81, 126.89, 126.84), 125.74,
125.48, 124.99, 123.47, 112.39, 109.57,
76.40, 45.74, 40.28, 39.36, 29.40, 29.10,
26.25, 26.06. MS (ESI): HRMS (ESI):
(m/z): calcd for C
30
H
30
N
2
O
6
+H: 515.2182,
found: 515.2180. [α]
D
25
= 0.1 (c = 0.004,
CH
2
Cl
2
).
Coating of HA and TCP
Bioceramics
Discs (d = 2.5 cm, h = 0.5 cm) of dense-
ly sintered HA and TCP biomaterials were
incubated in a solution of 8 at increasing
concentrations (0, 5 and 10 µM) for 24 h at
room temperature in the dark under slight
stirring. The discs were washed three times
with water and dried under vacuum for
24 h.
Cell Source and Culture Conditions
Human fetal osteoblasts were derived
by the explant technique from the femo-
ral bone of a 12-week old fetus according
to a protocol accepted by the Lausanne
Hospital and University Ethics Committee
and with the mother’s oral and written ap-
proval (protocol No 51/01, 2008). These
cells were used at passage 6. Cells were
routinely grown in DMEM medium con-
taining 4.5 g/l glucose, 10% fetal calf
serum (FCS) and antibiotics (all from
Invitrogen, Basel, Switzerland).
Click Reaction on FsOs
l-Azidohomoalanine (AHA) was pur-
chased from Invitrogen, bovine serum
albumin (BSA), from Sigma-Aldrich,
Buchs, Switzerland. FsOs (80–90% con-
fluent) were washed with warm (37 °C)
PBS and incubated in methionine-free
DMEMculturemedium containing 4.5 g/L
glucose, antibiotics (P/S) and 3% FCS for
30–60 min to deplete methionine reserves.
Then they were incubated for 4 h in the
presence of AHA (50 µM) in fresh com-
plete culture medium. The culture medium
was removed and the cell layer was washed
twice with PBS.
Stock solution of compound 4 (2.5
mM in PBS:DMF (7:3)) was prepared. For
microscopy experiments, the click reac-
tion was performed in a solution contain-
ing compound 4 (20–100 µM) in DMEM
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containing additional HEPES (20 µM).
Incubation was performed for 1 h at 25 °C.
The reaction mixture was removed and
two washings with PBS at 37 °C allowed
the complete removal of the reagents. The
cells were then fixed using a 4% formal-
dehyde in PBS for 10 min at 25 °C. After
two washings with warm PBS, the cells
were incubated with PBS containing 1%
BSA for 1 h at 25 °C and the labeling
was performed. Streptavidin-Cy3 (Sigma-
Aldrich) (1:100) and DAPI (4',6-diamidi-
no-2-phenylindole, Roche Diagnostics) (1
µg/mL in PBS) were then added and incu-
bated with the cells for 30 min in the dark.
After two washings with PBS during 5 min
in the dark, the cells were fixed using a 4%
formaldehyde solution in PBS at 4 °C.
Two additional washings with PBS were
performed. The chamber was removed
from the slide glass by using the chamber
removal device and the evaluation of the
click reaction was performed by fluores-
cence microscopy and slides photographed
under a fluorescence microscope (Zeiss
Axioplan 2).
Cell Viability Assay
Cell cultures were treated with com-
pound 4 (100 µM) in complete medium
and additional HEPES (20 µM) for 1 h at
room temperature. Then cell survival was
evaluated after 72 h to 144 h using the
WST-1 assay. The culture medium was
removed, cells were rinsed with DMEM
without phenol red (Invitrogen) and in-
cubated with the WST-1 reagent (Roche
Diagnostics), diluted 1:10 in DMEMwith-
out phenol red for 3 h. Optical density of
the supernatants was measured at 450 nm
in a multiwell-plate reader (iEMS Reader
MF, Labsystems, Bioconcept) against
a blank containing culture medium and
WST-1.
Click Reaction on the Biomaterial
Petri dishes (9 cm, Costar) were coat-
ed with 1000 µg/mL Rat Tail collagen I
(Invitrogen) according to the supplier’s
protocol and human fetal osteoblasts were
then grown in the dishes for 24 h until
the cells are 80–90% confluent. The cells
were washed with PBS and incubated in
methionine-free DMEM culture medium
(Invitrogen) for 60 min to deplete methio-
nine reserves. Then the cells were incubat-
ed overnight in the presence of AHA (50
µM final concentration) in fresh complete
methionine-free culture medium. The cul-
ture mediumwas removed and the cell lay-
ers were washed twice with PBS. Collagen
coating was degraded by adding 0.1 mg/
mL collagenase (Sigma-Aldrich) in PBS
at 37 °C for 45 min. The osteoblasts were
then counted. Three mL of the cell suspen-
sion (10
5
cells/mL) were added on unfunc-
tionalized HA and TCP biomaterials or on
HA and TCP biomaterials functionalized
with ligand 8, in a 6-well plate (Costar)
and incubated for 1 h at room temperature
under slight agitation. Then the discs were
washed once with PBS, fixed in cold meth-
anol (–20 °C) for 5 min and incubated in
5%BSA for 1 h at room temperature. Cells
were stained for 5 min at room temperature
with a solution containing 0.05% crystal
violet (Sigma-Aldrich) and 1.5% glacial
acetic acid in water. Cells were imaged by
stereomicroscopy (MZ16 FA Leica/DFC
480 Leica, 0.63 X and 1.6 X, zoom 72 X),
3 pictures for each treatment were taken
and the cell number was evaluated using
the IMAGE J software.
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